No Validity to No Safe Dose: Part II - The LNT Model and ‘Low Dose’ Epidemiology




By Mark G. Zellmer of Husch Blackwell LLP

For more on the author, Click Here.

Part I of this article demonstrated that the Linear No Threshold (“LNT”) model of carcinogenesis has no actual support in science. Part II will delve into two related issues:

• What argument is still presented in favor of LNT?
• How does LNT relate to the “low dose” epidemiological studies that plaintiffs rely upon?

The “Argument” for LNT

When science cannot back an argument, model, or hypothesis, its advocates will regularly resort to a simple dodge: it is the consensus view.

The …






UPCOMING CONFERENCES




HarrisMartin's Talcum Powder Litigation Conference: Onward and Upward!

April 26, 2023 - Washington, DC
Fairmont Washington, D.C. - Georgetown

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Key Litigation Updates and Lessons Learned

March 29, 2023 - Tucson, AZ
Omni Tucson National Resort

MORE DETAILS